Cancer BiologybioRxiv
Purinergic Ca2+ signaling as a novel mechanism of drug tolerance in BRAF mutant melanoma
P. E. Stauffer, J. Brinkley, D. A. Jacobson…·D. R. Tyson
This study identifies purinergic Ca2+ signaling via P2X7 receptors as a mechanism enabling drug tolerance in BRAF-mutant melanoma, with implications for overcoming treatment resistance.
DOI 10.3390/cancers16132426